UNLOCK THE POWER OF PEPTIDES FOR OPTIMAL AGING

How Can Retina Bioregulators aid Eyesight?

Retina bioregulators are biologically active dietary supplements designed to regulate and normalize the function of the retina and aid vision. This can be beneficial not only for ongoing good vision but for those who suffer from vision related health problems such as diabetic retinopathy, pigment retinitis and age-related macular degeneration.

Retina bioregulators work using short-chain amino acid sequences that act as epigenetic “gene switches.” They bind DNA and help cells manufacture proteins more effectively—triggering organ-specific repair and regeneration pathways.

The way a retina bioregulator works means it can have some specific benefits on vision:

Nature’s Marvels Retina Bioregulator

Nature’s Marvels Retina Bioregulator conforms to the formula used in the original peptide bioregulators created by Prof. Vladmir Khavinson.

The Nature’s Marvels Retina Bioregulator formula consists of Amino Acid complex A-11 enclosed in a HPMC Vegetable Capsule. The amino acids are derived from organ meats sourced extract from the bone marrow of young animals. It is available in boxes of 20 x 10mg capsules.

A typical dosage of this bioregulator is similar to other bioregulators in the Nature’s Marvels range.

N-acetylcarnosine

N-acetylcarnosine  is the primary active ingredient in the Can-C™ range of eye drops and capsules designed to normalize cataract impairment and aid good vision. Often abbreviated to NAC, N-acetylcarnosine is a special analogue of the di-peptide carnosine. It is a potent antioxidant and works to eradicate free radicals, “rogue” cells in the body that are the root cause of tissue damage and accelerated aging. This protective effect is particularly important for the lens, where oxidative damage can contribute to the development of cataracts and age-related vision decline.

Trials have been undertaken in the role that NAC can play with aiding vision. Biophysicist Dr Babizhayey, lead researcher in these trials, has evidenced that NAC/branded Can-C™ can improve the vision in cataract patients when compared to those who were given a placebo, although a caveat of this was that patients who achieved optimal benefit had vision no worse than 0.3. In addition, the studies involved were primarily with those who had cortical and subscapular cataracts (those with a membrane component) and the results were less pronounced in patients who had brunescent nuclear cataracts (these are characterized by a dark brown discoloration of the lens nucleus).

By counteracting harmful oxidative processes, N-acetylcarnosine offers a promising, non-invasive approach to preserving healthy vision as we age.